Avery Dennison Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report, dated November 15, 2010, details a significant capital structure event for Avery Dennison Corporation. The filing reports the closing of a remarketing transaction involving the Company's Corporate HiMEDS Units.
Key Financial Metrics
- Debt Reduction: The Company purchased and cancelled $109,351,000 aggregate principal amount of its 5.350% Senior Notes due 2020.
- Cash Proceeds: The Company received $109,351,000 in cash proceeds from the issuance of common stock to settle the purchase obligation of HiMEDS Unit holders.
- Equity Issuance: The Company issued 2,133,656 shares of common stock (par value $1.00) to HiMEDS Unit holders.
- Net Cash Impact: The cash proceeds from the stock issuance offset the $109,624,378 purchase price of the Notes, resulting in a net cash outflow of approximately $273,378 (excluding cash paid for fractional shares).
Material Changes
The primary material change is the complete extinguishment of the 5.350% Senior Notes due 2020. Upon closing, the Indenture related to these Notes was satisfied and discharged. Concurrently, the Company converted the debt component of its Corporate HiMEDS Units into equity, issuing shares to unit holders.
Outlook, Risks, and Commentary
The transaction was conducted pursuant to a Remarketing Agreement dated September 27, 2010, with JP Morgan Securities LLC as the Remarketing Agent. The remarketing was registered under an effective Form S-3. The filing does not provide specific forward-looking guidance, risk factors, or management commentary beyond the mechanics of the transaction closure.
Investor Verification Checklist
- Verify the exact number of shares issued (2,133,656) and the treatment of fractional shares.
- Confirm the net cash impact after accounting for cash paid in lieu of fractional shares.
- Review the attached Remarketing Agreement (Exhibit 1.1) for any remaining covenants or conditions.
- Check subsequent filings for the impact of this debt reduction on the Company's leverage ratios and interest expense.